12.05.2025
Arctic Bioscience AS’ Annual General Meeting will be held Monday 26 May 2025 at 11:00 (CET), as a digital meeting.
Shareholders are encouraged to cast their votes in advance of the General Meeting or grant the Chair of the Board a proxy, with or without voting instructions.
The deadline for registration of attendance, advance votes, proxy or instructions is 22 May 2025 at 16:00 (CET). For attendance at the live event, please follow the instructions in the notice.
For further information, see the attached Notice of the Annual General Meeting, which can also be accessed from the company’s website (https://arctic-bioscience.com/investors/general-meetings/).
Board of Directors proposal:
Proposed board members for the next period are:
Proposed new board member Olav Sindre Kriken is a Norwegian citizen from Ørsta based in Palo Alto, California. Mr. Kriken is an experienced Founder and Businessman with a solid record within business innovation and growth. He is skilled in Product-Led Growth, Business Modelling, Marketing Management and Digital Strategy. The nomination of Mr. Kriken to the company board is aligned with the company growth within product sales through established and new distributions channels with strategic utilization of the opportunities with AI and SoMe.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For more information, please contact:
Christer L. Valderhaug
CEO
Phone: +47 920 84 601
E-mail: christer@arctic-bioscience.com
Jone R. Slinning
CFO
Mobile: +47 948 75 469
E-mail: jone@arctic-bioscience.com
About Arctic Bioscience
Arctic Bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on unique bioactive marine compounds.
The company is developing HRO350 – a novel oral drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. This is a large patient group in need of new effective medicines with beneficial safety profile.
Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as well as finished goods under the ROMEGA® brand.
Arctic Bioscience is led by a highly skilled team of talents with diverse and highly relevant background.